Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL-Reference-Cited by-同舟云学术

Extreme-risk category: High prevalence among stable coronary patients and an emerging widening treatment gap in achieving LDL-cholesterol less than 55 mg/dL

Published:2018-08 Issue: Volume:275 Page:262-264
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Rallidis Loukianos S.,Kiouri Estela,Katsimardos Andreas,Kotakos Christos

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference12 articles.

1. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions

2. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: results from the Dyslipidemia International Study II;Gitt;Atherosclerosis,2017

3. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N. Engl. J. Med.,2004

4. Attainment of optional low-density lipoprotein cholesterol goal of less than 70 mg/dl and impact on prognosis of very high risk stable coronary patients: a 3 year follow-up;Rallidis;Expert Opin. Pharmacother.,2011

5. American association of clinical endocrinologists and american college of endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease;Jellinger;Endocr. Pract.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study;The Anatolian Journal of Cardiology;2023

2. Perkütan Koroner Girişim Sonrası Periyodik Muayene Zaman Aralığı ve Sıklığının İkinci "Akut Koroner Sendrom" Yaşanmasına Etkisi;Konuralp Tıp Dergisi;2022-08-01

3. Rationale, Criteria, and Impact of Identifying Extreme Risk in Patients with Atherosclerotic Cardiovascular Disease;Cardiology Discovery;2022-06

4. Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based Study;Journal of Lipid and Atherosclerosis;2022

5. Optimum Treatment Strategy in Chronic Coronary Syndromes: the New Trials vs the Current Guidelines;Rational Pharmacotherapy in Cardiology;2021-11-03